MSBIO Company Description

MSBIO, Inc. engages in the developing, manufacturing, and selling products that restores and treats damaged human tissues in South Korea.

The company offers allograft tissue products, such as GenerFill H, MYBONE, MS Aminion, and MYDERM. It also provides medical devices, including MYGEN, a low antigenicity collagen injector; MS hydrolifting; MS Collagen, a low antigenicity atelocollagen; and MYGIS, a resorbable collagen membrane for GBR.

The company was founded in 2015 and is headquartered in Seongnam-si, South Korea.

MSBIO, Inc.

Country	South Korea
Founded	2015
Industry	Surgical and Medical Instruments and Apparatus
CEO	Sungpo Kim

Contact Details

Address: #1414, #1413, 124, Sagimakgol-ro Seongnam-si, 13207 South Korea
Phone	82 31 776 3380
Website	msbio.co.kr

Stock Details

Ticker Symbol	0013Y0
Exchange	KOSDAQ
Reporting Currency	KRW
ISIN Number	KR70013Y0009
SIC Code	3841

Key Executives

Name	Position
Sungpo Kim	Chief Executive Officer